2027年までのアジア太平洋医療灌流技術市場予測 - 新型コロナウイルス感染症の影響と技術別(低体温装置灌流および正常温装置灌流)、臓器タイプ(心臓、肺、腎臓、肝臓、その他)による地域分析。コンポーネント (灌流ポンプ、人工肺、人工心肺、モニタリング システム、カニューレ、その他)
No. of Pages: 122 | Report Code: TIPRE00021069 | Category: Life Sciences
No. of Pages: 122 | Report Code: TIPRE00021069 | Category: Life Sciences
灌流とは、循環系またはリンパ系を通って臓器または組織への液体の通過であり、通常、組織内の毛細血管床への血液の送達。灌流は、血液が組織に送達される速度、または単位組織質量あたりの単位時間あたりの血液の量（血流）として測定されます。大手術中は、身体の恒常性だけに任せるのではなく、関係する医療専門家によって灌流が維持および管理される必要があります。
アジア太平洋地域の医療灌流技術市場は、2019 年の 1 億 4,860 万米ドルから 2027 年には 2 億 1,230 万米ドルに達すると予想されています。市場は CAGR で成長すると推定されています2020年から2027年までは4.7%。この市場の成長は、心血管疾患の有病率の上昇や臓器移植の増加などの主要な推進要因により拡大すると推定されています。ただし、高額な臓器移植手術のため、市場は予測期間中に成長が鈍化すると予想されます。
技術に基づいて、医療灌流技術市場は低体温機械灌流と正常体温機械灌流に分類されます。臓器の種類に基づいて、医療灌流技術市場は心臓、肺、腎臓、肝臓などに分類されます。医療灌流技術市場は、コンポーネントに基づいて、灌流ポンプ、人工肺、人工心肺、モニタリング システム、カニューレなどに分類されます。
レポートに含まれる医療灌流技術市場の主要な一次および二次情報源の一部世界保健機関 (WHO)、CFDA (中国食品医薬品局)、その他。
技術別
臓器の種類別
成分別
国別
Strategic insights for Asia Pacific Medical Perfusion Technology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 148.6 Million |
| Market Size by 2027 | US$ 212.3 Million |
| Global CAGR (2020 - 2027) | 4.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技術
|
| Regions and Countries Covered | アジア太平洋
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Medical Perfusion Technology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Medical Perfusion Technology Market is valued at US$ 148.6 Million in 2019, it is projected to reach US$ 212.3 Million by 2027.
As per our report Asia Pacific Medical Perfusion Technology Market, the market size is valued at US$ 148.6 Million in 2019, projecting it to reach US$ 212.3 Million by 2027. This translates to a CAGR of approximately 4.7% during the forecast period.
The Asia Pacific Medical Perfusion Technology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Medical Perfusion Technology Market report:
The Asia Pacific Medical Perfusion Technology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Medical Perfusion Technology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Medical Perfusion Technology Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Medical Perfusion Technology Market
